Ledger.Open graph →
SEC Form D · filed October 6, 2021

DiaMedica Therapeutics Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MINNEAPOLIS, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

R. M. Giuffre · MINNEAPOLIS, MNDirectorRichard D. Pilnik · Yorba Linda, CADirectorCharles P. Semba · MINNEAPOLIS, MNDirectorJames T. Parsons · MINNEAPOLIS, MNDirectorAmy L. Burroughs · MINNEAPOLIS, MNDirectorHarry W. Alcorn Jr · MINNEAPOLIS, MNExecScott Kellen · Minneapolis, MNExecRick Pauls · Minneapolis, MNExec · DirectorSydney Gilman · MINNEAPOLIS, MNExecR. M. Giuffre · MINNEAPOLIS, MNDirectorAmy L. Burroughs · MINNEAPOLIS, MNDirectorHarry W. Alcorn Jr · MINNEAPOLIS, MNExecRichard D. Pilnik · Yorba Linda, CADirectorCharles P. Semba · MINNEAPOLIS, MNDirectorScott Kellen · Minneapolis, MNExecRick Pauls · Atlanta, GAExec · DirectorSydney Gilman · MINNEAPOLIS, MNExecJames T. Parsons · MINNEAPOLIS, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗